Insider Transactions in Q3 2020 at Moderna, Inc. (MRNA)
Insider Transaction List (Q3 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 19
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.13%
|
$594,000
$66.74 P/Share
|
|
Aug 17
2020
|
Flagship Ventures Fund Iv General Partner LLC Director |
SELL
Other acquisition or disposition
|
Indirect |
11,053,049
-52.3%
|
-
|
|
Aug 17
2020
|
Stephane Bancel Chief Executive Officer |
BUY
Other acquisition or disposition
|
Direct |
50,010
+0.74%
|
-
|
|
Aug 17
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
20,000
-100.0%
|
$1,380,000
$69.06 P/Share
|
|
Aug 17
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+41.67%
|
$400,000
$20.04 P/Share
|
|
Aug 14
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.8%
|
$762,174
$69.32 P/Share
|
|
Aug 13
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
15,000
-0.25%
|
$1,020,000
$68.45 P/Share
|
|
Aug 13
2020
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.5%
|
$0
$0.99 P/Share
|
|
Aug 13
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
20,000
-0.13%
|
$1,380,000
$69.05 P/Share
|
|
Aug 12
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
5,000
-0.04%
|
$355,000
$71.5 P/Share
|
|
Aug 12
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
2,000
-0.02%
|
-
|
|
Aug 12
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
18,000
-0.13%
|
$1,350,000
$75.74 P/Share
|
|
Aug 10
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
20,000
-100.0%
|
$1,480,000
$74.27 P/Share
|
|
Aug 10
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+41.67%
|
$400,000
$20.04 P/Share
|
|
Aug 10
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
8,097
-0.09%
|
$599,178
$74.27 P/Share
|
|
Aug 07
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.78%
|
$817,404
$74.55 P/Share
|
|
Aug 06
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$750,000
$75.82 P/Share
|
|
Aug 05
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.02%
|
-
|
|
Aug 05
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.13%
|
$693,000
$77.49 P/Share
|
|
Aug 03
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
20,000
-100.0%
|
$1,480,000
$74.89 P/Share
|
|
Aug 03
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+41.67%
|
$400,000
$20.04 P/Share
|
|
Aug 03
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
20,000
-1.01%
|
$1,480,000
$74.89 P/Share
|
|
Aug 03
2020
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+0.5%
|
$0
$0.99 P/Share
|
|
Aug 03
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
8,097
-0.09%
|
$599,178
$74.89 P/Share
|
|
Jul 31
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.57%
|
$839,496
$76.09 P/Share
|
|
Jul 30
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$770,000
$77.98 P/Share
|
|
Jul 29
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.02%
|
-
|
|
Jul 29
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.13%
|
$738,000
$82.0 P/Share
|
|
Jul 27
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
20,000
-52.76%
|
$1,560,000
$78.67 P/Share
|
|
Jul 27
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+41.67%
|
$400,000
$20.04 P/Share
|
|
Jul 24
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.37%
|
$773,220
$70.53 P/Share
|
|
Jul 24
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
10,000
-0.05%
|
$700,000
$70.95 P/Share
|
|
Jul 23
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
30,000
-0.13%
|
$2,370,000
$79.03 P/Share
|
|
Jul 23
2020
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+0.5%
|
$0
$0.99 P/Share
|
|
Jul 23
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$820,000
$82.22 P/Share
|
|
Jul 22
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.01%
|
-
|
|
Jul 22
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.13%
|
$711,000
$79.61 P/Share
|
|
Jul 20
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
20,000
-39.21%
|
$1,680,000
$84.49 P/Share
|
|
Jul 20
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+41.67%
|
$400,000
$20.04 P/Share
|
|
Jul 20
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
6,326
-0.01%
|
$531,384
$84.33 P/Share
|
|
Jul 17
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.2%
|
$983,094
$89.45 P/Share
|
|
Jul 16
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$800,000
$80.39 P/Share
|
|
Jul 15
2020
|
Elizabeth G Nabel Director |
SELL
Open market or private sale
|
Direct |
73,975
-100.0%
|
$6,435,825
$87.84 P/Share
|
|
Jul 15
2020
|
Elizabeth G Nabel Director |
BUY
Exercise of conversion of derivative security
|
Direct |
59,631
+22.36%
|
$1,013,727
$17.51 P/Share
|
|
Jul 15
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.01%
|
-
|
|
Jul 15
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.13%
|
$783,000
$87.84 P/Share
|
|
Jul 13
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
10,000
-0.04%
|
$710,000
$71.07 P/Share
|
|
Jul 13
2020
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.5%
|
$0
$0.99 P/Share
|
|
Jul 13
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
20,000
-33.72%
|
$1,420,000
$71.08 P/Share
|
|
Jul 13
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+41.67%
|
$400,000
$20.04 P/Share
|